Disney's Mulan misadventure

Why are so many boycotting this would-be blockbuster?

The smartest insight and analysis, from all perspectives, rounded up from around the web:

Disney's summer blockbuster is becoming a horror show, said Christopher Palmeri at Bloomberg. What was "supposed to be another $1 billion" megahit, the live-action remake of 1998's hugely popular animated film Mulan, is "proving to be a political hot potato." The controversy began more than a year ago, when the movie's leading actress, Liu Yifei, "voiced her support for the mainland Chinese government during Hong Kong pro-democracy protests." Complaints that Disney was catering to China's Communist Party gained steam when viewers who paid $30 to stream the film noticed "special thanks" in the closing credits to Chinese government entities in Xinjiang. That's the region where China has set up concentration camps for as many as a million Uighurs, a Muslim minority. The revelation prompted calls for a boycott, even as "the coronavirus knocked out Mulan's chances of getting a successful run in theaters." Now China, in a backlash against the backlash, has refused to allow its media to promote the film, which earned a meager $23 million in its Chinese theatrical debut.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us